Skip to main content
. 2021 Jan 3;25(3):1839–1854. doi: 10.1007/s11030-020-10169-0

Fig. 8.

Fig. 8

Fig. 8

The inhibitory binding interactions, of a CoViTris2020; b ChloViD2020; c Remdesivir (active metabolite form), with the active amino acids of the SARS-CoV-2 RdRp (2D and 3D representations, respectively)